Is your child currently experiencing moderate to severe ulcerative colitis flare-ups? Local Crohn’s disease clinical trial is testing a potential new medication to see if it may reduce joint pain, fistula, diarrhea, frequent fevers, and/or joint pain associated with moderate to severe ulcerative colitis.
If you’re concerned about how moderate to severe ulcerative colitis affects your child’s life, find out more about the Crohn’s disease clinical trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child qualifies.

We are looking for children at least 2 years of age but under 18 to join a Crohn’s disease clinical research study to help us discover more about treating Crohn’s. If you are looking for a potential new treatment option for Crohn’s or moderate to severe Crohn’s disease (including associated symptoms such as joint pain, stomach pain, cramps, frequent fevers and/or joint pain), consider one of our IBD clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your children at least 2 years of age but under 18 may be eligible to take part.

Your child may be eligible to take part in the IBD clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child qualifies.

Is your child currently experiencing moderately to severely active ulcerative colitis flare-ups? Local CD study is testing a potential new medication to see if it may reduce diarrhea with pus, failure to thrive, cramps, frequent fevers, and/or joint pain associated with moderately to severely active ulcerative colitis.
If you’re concerned about how moderately to severely active ulcerative colitis affects your child’s life, find out more about the CD study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

We are looking for young people 2 to 17 years of age to join a CD research to help us discover more about treating Crohn’s disease. If you are looking for a potential new treatment option for Crohn’s disease or CD (including associated symptoms such as abdominal cramps, perianal fistula, cramps, chronic fatigue and/or joint pain), consider one of our IBD research studies. All eligible participants will receive no-cost study-related care and study medication. Your young people 2 to 17 years of age may be eligible to take part.

Your child may be eligible to take part in the IBD research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

Is your child currently experiencing Crohn’s and UC flare-ups? Local Crohn’s disease (CD) research is testing a potential new medication to see if it may reduce fever, perianal fistula, constant need to poop, malnutrition, and/or liver disease associated with Crohn’s and UC.
If you’re concerned about how Crohn’s and UC affects your child’s life, find out more about the Crohn’s disease (CD) research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited, so please respond now.

We are looking for young people 2–17 years old to join a Crohn’s disease clinical research to help us discover more about treating CD and UC. If you are looking for a potential new treatment option for CD and UC or Crohn’s disease (CD) (including associated symptoms such as weight loss, unexplained weight loss, constant need to poop, malnutrition and/or liver disease), consider one of our CD studies. All eligible participants will receive no-cost study-related care and study medication. Your young people 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the CD studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited, so please respond now.

Is your child currently experiencing Crohn’s and UC flare-ups? Local Crohn’s disease (CD) medical research study is testing a potential new medication to see if it may reduce swollen joints, fatigue, bloody stool, weight loss, and/or joint pain associated with Crohn’s and UC.
If you’re concerned about how Crohn’s and UC affects your child’s life, find out more about the Crohn’s disease (CD) medical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Is your child eligible?

We are looking for children to join a clinical trial to help us discover more about treating moderate to severe UC. If you are looking for a potential new treatment option for moderate to severe UC or Crohn’s disease (CD) (including associated symptoms such as cramping, kidney stones, rectal pain, weight loss and/or anemia), consider one of our GI research studies. All eligible participants will receive no-cost study-related care and study medication. Your children may be eligible to take part.

Your child may be eligible to take part in the GI research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Is your child eligible?

Is your child currently experiencing CD flare-ups? Local clinical trial is testing a potential new medication to see if it may reduce abdominal cramps, joint pain, rectal pain, weight loss, and/or anemia associated with CD.
If you’re concerned about how CD affects your child’s life, find out more about the clinical trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to to join.

We are looking for children at least 2 years of age but under 18 to join a Crohn’s disease clinical trial to help us discover more about treating gastrointestinal disease. If you are looking for a potential new treatment option for gastrointestinal disease or UC (including associated symptoms such as recurrent diarrhea, reduced appetite, constant need to poop, chronic fatigue and/or liver disease), consider one of our studies. All eligible participants will receive no-cost study-related care and study medication. Your children at least 2 years of age but under 18 may be eligible to take part.

Your child may be eligible to take part in the studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to to join.